Physician profile
Ryan T Anthony
NPI 1902303803
$7,482.65
in general payments reported to CMS, 2019-2025
9 companies · $3,780 in 2025
The $3,780 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,795 · 2024: $907 · 2025: $3,780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,530 · Travel and Lodging: $2,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,529.63 |
| Travel and Lodging | $2,953.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,997.51 | 2025 | Va-Lcp, Na |
| Stryker Corporation | $2,638.87 | 2023-2025 | Gamma, Axsos, T2 |
| Arthrex, INC. | $938.36 | 2023 | |
| Depuy Synthes Sales INC. | $537.93 | 2024-2025 | Na, Tfn-Advance, Lcp |
| Medinc of Texas | $174.67 | 2023 | |
| Globus Medical, INC. | $93.91 | 2023 | Tibial Nail, Mini Fragment System |
| Zimmer Biomet Holdings, INC. | $46.05 | 2024 | Ncb |
| Smith+Nephew, INC. | $34.52 | 2024 | Evos |
| Orthalign INC | $20.83 | 2023 | Orthalign Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Anthony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.